Literature DB >> 11897756

Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.

Giuseppe Mancia1, Stefano Carugo, Guido Grassi, Arturo Lanzarotti, Riccardo Schiavina, Giancarlo Cesana, Roberto Sega.   

Abstract

Previous studies have shown that in the population, only a minority of treated hypertensive patients achieve blood pressure (BP) control. Whether and to what extent this inadequate control has reflection on hypertension-related organ damage has never been systematically examined. In 2051 subjects belonging to the PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) Study population, we measured office, home, and 24-hour ambulatory BP values, together with echocardiographic left ventricular mass and wall thickness. Based on the fraction on antihypertensive treatment and on measurements of increased or normal office, home, or 24-hour ambulatory BP values, subjects were classified as normotensives, untreated hypertensives, treated hypertensives with inadequate BP control, and treated hypertensives with effective BP control. Compared with values in the normotensive group, left ventricular mass index, left ventricular wall thickness, and prevalence of left ventricular hypertrophy were markedly increased not only in untreated hypertensive patients but also in treated hypertensives with inadequate BP control. Echocardiographic abnormalities were less in treated hypertensives with BP control than in patients with inadequate BP control, but values were still clearly greater than in normotensive subjects. This was the case regardless whether BP control was assessed by office, home, and/or ambulatory values. Our data provide evidence that in the hypertensive fraction of the population, cardiac structural alterations can be frequently found in both the presence and absence of antihypertensive treatment. They also imply that even effective treatment of hypertension does not allow complete reversal of the cardiac organ damage characterizing high BP states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897756     DOI: 10.1161/hy0302.104669

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

Review 1.  Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.

Authors:  Timothy L Reudelhuber; Kenneth E Bernstein; Patrick Delafontaine
Journal:  Hypertension       Date:  2007-04-23       Impact factor: 10.190

Review 2.  Management of hypertension in patients with left ventricular hypertrophy.

Authors:  Cesare Cuspidi; Carla Sala; Alberto Zanchetti
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 3.  Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.

Authors:  M Bombelli; Rita Facchetti; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 4.  Hypertension Survey in Italy: Novel Findings from the Campania Salute Network.

Authors:  Eugenio Stabile; Raffaele Izzo; Francesco Rozza; Maria Angela Losi; Nicola De Luca; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-01

Review 5.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 6.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

7.  Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.

Authors:  Hui Chen; Min Li; Lei Liu; Danjun Zhu; Gang Tian
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-19

8.  Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran.

Authors:  Sahar Fallahi-Shahabad; Mohsen Mazidi; Alireza Tavasoli; Peyman Rezaie; Fatemeh Rohani; Simindokht Habibzadeh; Emadodin Darchini-Maragheh; Zohreh Sadat Sang Sefidi; Mohammad Safarian; Majid Ghayour Mobarhan; Mohammad Taghi Rajabi; Abdolreza Norouzy; Seyed Mohammad Reza Parizadeh; Saeid Akhlaghi; Shima Tavalaie; Fatemeh Firouzi; Mohsen Nematy
Journal:  Indian J Gastroenterol       Date:  2016-05-21

9.  Efficacy and tolerability of delapril plus indapamide versus lisinopril plus hydrochlorothiazide combination treatments in mild to moderate hypertension: a multicenter, randomized clinical study.

Authors:  Giovanni Cremonesi; Luca Cavalieri; Stefano Bacchelli; Daniela Degli Esposti; Ivo Cikes; Jurij Dobovisek; Jan Zeman; Claudio Borghi; Ettore Ambrosioni
Journal:  Curr Ther Res Clin Exp       Date:  2003-05

10.  Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients.

Authors:  Franco Cipollini; Enrica Arcangeli; Giuseppe Seghieri
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.